Pingan Lian

发表

Sodium-glucose cotransporter protein-2 inhibitors and glucagon-like peptide-1 receptor agonists versus thiazolidinediones for non-alcoholic fatty liver disease: A network meta-analysis

Xiansheng Huang, C. Ding, Yaxin Tang, 2022, Acta Diabetologica.

Alterations in sorting and secretion of hepatic apoA5 induce hypertriglyceridemia due to short-term use of olanzapine

Xiansheng Huang, W. Dai, Yiqi Zhang, 2022, Frontiers in Pharmacology.

Metformin Ameliorates Hepatic Steatosis induced by olanzapine through inhibiting LXRα/PCSK9 pathway

Xiansheng Huang, W. Dai, Yaxin Tang, 2022, Scientific Reports.

PCSK9 dysregulates cholesterol homeostasis and triglyceride metabolism in olanzapine‐induced hepatic steatosis via both receptor‐dependent and receptor‐independent pathways

Xiansheng Huang, Wenqiang Zhu, Piaopiao Huang, 2024, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.